The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A noninvasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.
T. Nakamura
No relevant relationships to disclose
N. Sueoka-Aragane
No relevant relationships to disclose
K. Iwanaga
No relevant relationships to disclose
A. Sato
No relevant relationships to disclose
K. Komiya
No relevant relationships to disclose
T. Abe
No relevant relationships to disclose
N. Ureshino
No relevant relationships to disclose
S. Hayashi
No relevant relationships to disclose
E. Sueoka
No relevant relationships to disclose
S. Kimura
No relevant relationships to disclose